Key indicators: single-crystal X-ray study; T = 298 K; mean (C-C) = 0.017 Å; R factor = 0.050; wR factor = 0.119; data-to-parameter ratio = 14.3.
In the title compound, [Fe 2 Sb(C 5 H 5 ) 2 (C 6 H 5 ) 3 (C 7 H 7 NO) 2 ] or [Sb(C 6 H 5 ) 3 {Fe(C 5 H 5 )(C 7 H 7 NO)} 2 ], the Sb center has a slightly distorted trigonal-bipyramidal geometry, with the three phenyl ligands in equatorial positions and the two O atoms from the ferrocenylethanone oximate ligands in axial positions. The crystal structure is stabilized by two intermolecular C-HÁ Á Á interactions.
Related literature
For antimony compounds with cytotoxicity and antitumor activities, see: Takahashi et al. (2002) . For a related structure, see: Sharma et al. (2003) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). sup-2 Figures   Fig. 1 . The molecular structure of (I) with displacement ellipsoids for non-hydrogen atoms drawn at the 30% probability level. (7) 0.005 (7) −0.012 (7) 0.001 (6) C34 0.095 (8) 0.099 (7) 0.054 (7) −0.010 (6) 0.007 (7) −0.001 (6) C35 0.097 (8) 0.089 (7) 0.060 (7) 0.006 (6) 0.010 (6) 0.000 (5) C36 0.087 (7) 0.093 (7) 0.054 (6) 0.012 (6) 0.000 (6) −0.001 (5) C37 0.071 (7) 0.080 (7) 0.069 (7) 
